A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Conditions:   Localized Osteosarcoma;   Metastatic Osteosarcoma;   Resectable Osteosarcoma;   Unresectable Osteosarcoma Interventions:   Procedure: Bone Scan;   Drug: Cabozantinib S-malate;   Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Doxorubicin Hydrochloride;   Procedure: Magnetic Resonance Imaging;   Drug: Methotrexate;   Procedure: X-Ray Imaging Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2023 Category: Research Source Type: clinical trials

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Conditions:   Localized Osteosarcoma;   Metastatic Osteosarcoma;   Resectable Osteosarcoma;   Unresectable Osteosarcoma Interventions:   Drug: Cabozantinib S-malate;   Drug: Methotrexate;   Drug: Doxorubicin Hydrochloride;   Drug: Cisplatin;   Procedure: X-Ray Imaging;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Procedure: Bone Scan Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials